Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun;99(6):1119-1128.
doi: 10.1002/ajh.27224. Epub 2024 Jan 31.

Neutrophils in sickle cell disease: Exploring their potential role as a therapeutic target

Lydian A de Ligt  1   2   3 , Aafke E Gaartman  1   2 , Bart J Biemond  1 , Karin Fijnvandraat  2   3 , Robin van Bruggen  2 , Erfan Nur  1   2
Affiliations
Free article
Review

Neutrophils in sickle cell disease: Exploring their potential role as a therapeutic target

Lydian A de Ligt et al. Am J Hematol. 2024 Jun.
Free article

Abstract
in English, Dutch

Factors influencing the activation of neutrophils in SCD and the potential neutrophil-mediated ameliorating effects of therapies in SCD.

Sickle cell disease (SCD) is an inherited hemoglobinopathy characterized by chronic hemolytic anemia and recurrent microvascular occlusions, resulting in acute painful events and progressive organ damage. Although primarily a red blood cell disorder, the pathophysiology of SCD is increasingly characterized as a complex interplay between several different cell types and cellular processes. Evidence is accumulating that neutrophils are phenotypically different in SCD and have a significant contribution in the pathophysiology of the disease. In this review, we summarize the currently available evidence on the role of neutrophils in SCD pathophysiology, demonstrating that neutrophils in SCD have an activated phenotype and play an important role in vaso‐occlusion and inflammation in SCD. Activation of neutrophils in SCD is primarily driven by hemolysis and ischemia–reperfusion injury. The ameliorating effects of treatments, for example, hydroxyurea, might be partly mediated by decreasing neutrophil counts and reversing the pro‐inflammatory properties. Whether the novel anti‐sickling therapies, reducing hemolysis, have an anti‐inflammatory effect on neutrophils, remains to be elucidated.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

REFERENCES

    1. Buchanan GR, DeBaun MR, Quinn CT, Steinberg MH. Sickle cell disease. Hematology Am Soc Hematol Educ Program. 2004;2004:35‐47. doi:10.1182/asheducation‐2004.1.35
    1. Nader E, Romana M, Connes P. The red blood cell‐inflammation vicious circle in sickle cell disease. Front Immunol. 2020;11:454. doi:10.3389/fimmu.2020.00454
    1. West MS, Wethers D, Smith J, Steinberg M. Laboratory profile of sickle cell disease: a cross‐sectional analysis. The cooperative study of sickle cell disease. J Clin Epidemiol. 1992;45(8):893‐909. doi:10.1016/0895‐4356(92)90073‐v
    1. Anyaegbu CC, Okpala IE, Akren'Ova YA, Salimonu LS. Peripheral blood neutrophil count and candidacidal activity correlate with the clinical severity of sickle cell anaemia (SCA). Eur J Haematol. 1998;60(4):267‐268. doi:10.1111/j.1600‐0609.1998.tb01036.x
    1. Kinney TR, Sleeper LA, Wang WC, et al. Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The cooperative study of sickle cell disease. Pediatrics. 1999;103(3):640‐645. doi:10.1542/peds.103.3.640

MeSH terms

LinkOut - more resources